Palvella Therapeutics PVLA
NASDAQ PVLA
$133.30 +0.57 (+0.43%)
As of: Oct 2, 2026 · 9:43 AM EDT

Palvella Therapeutics (PVLA) Total Debt (2013 - 2014)

Updated

Palvella Therapeutics (PVLA) recorded Total Debt of $1.27 million in FY2014, down 23.1% from $1.65 million in FY2013.

Analysis

Palvella Therapeutics (PVLA) Total Debt (2013 - 2014) Analysis & Trends

  • Per Business Quant data, PVLA's Total Debt was $1.65 million in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 49.04 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 70.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -111.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 26.25 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Palvella Therapeutics 1.99 Bn 1.73 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 1.27 Mn
Sep 30, 2014 3,474.00
Jun 30, 2014 474.00
Dec 31, 2013 1.65 Mn
API Access

Palvella Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=PVLA&period=max&api_key=YOUR_API_KEY